It has been reported that the cytotoxic effects of oxaliplatin in CRC can be enhanced by tenovin-6 through upregulating DR-5,14 suggesting that modulation of DR-mediated signaling may affect the effects of oxaliplatin-based chemotherapy. The gene discussed is TNFRSF10B; the disease is colorectal carcinoma.